N/A N=400 Randomized Single-blind Treatment

The Health Access and Recovery Peer Program

Hypertension · Arthritis · Coronary Artery Disease · Hepatitis · Diabetes

Bottom Line

View on ClinicalTrials.gov: NCT01725815 ↗

Enrolled (actual)

400

Serious AEs

0.0%

Results posted

Oct 2019

Primary outcome: Primary: Health Related Quality of Life (HRQOL) — 32.73; 32.74; 34.49; 33.89 score on a scale

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: HARP Intervention (Behavioral)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Emory University
Primary completion: Jun 2016

Outcome Measures

Outcome	Result	p-value
PRIMARY Health Related Quality of Life (HRQOL)	32.73; 32.74; 34.49; 33.89; 35.42; 34.15	—
SECONDARY Behavioral Activation	57.4; 55.7; 61.6; 56.4; 60.5; 57.2	—
SECONDARY Dietary Intake	10.1; 9.8; 10.1; 9.3; 10.2; 9.4	—
SECONDARY Medication Adherence	0.92; 0.94; 0.79; 0.97; 0.84; 0.89	—

Summary

Individuals with serious mental illnesses (SMI) face high rates of medical comorbidity as well as challenges in managing these conditions. A growing workforce of certified peer specialists is available to help these individuals more effectively manage their health and health care. However, there is little existing research examining the effectiveness of peer-led medical self-management programs for this population. in this trial, participants were randomized to either the Health and Recovery Peer program (HARP), a medical disease self-management program led by certified peer specialists, or to care as usual. Assessments were conducted at baseline, 3 months, and 6 months.

Eligibility Criteria

Inclusion Criteria

On CMHC roster of active patients.
Presence of a serious mental illness (schizophrenia, schizoaffective disorder, bipolar disorder, major depression, obsessive-compulsive disorder, or post-traumatic stress disorder
Chronic Medical Condition as noted in the CMHC chart or via self-report: (hypertension; arthritis; heart disease; diabetes; and asthma/COPD),

Exclusion Criteria

cognitive impairment based on a score of > 3 on a 6-item, validated screener developed for clinical research

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01725815). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.